European Perspectives

NextLevel 2016
, Scientific Consultant - November 01, 2016
Last week, medical affairs leaders gathered in London for NextLevel’s Medical Affairs Forum. At the congress, I was honored to chair the Best Practices in Late Phase Research track and meet with many industry leaders. Presenters...
ISPOR EU 2016
UBC - October 20, 2016
Vienna is known for its rich musical history and stunning imperial palaces, but next week the City of Music will draw crowds for ISPOR’s Annual European Congress.  From scientific presentations and consultations to sightseeing...
Tagged in:
Webinar: The Right Studies for Your Evidence Needs
UBC - October 12, 2016
Register Now:  Free Webinar - 17 November @ 10 a.m. EST As our industry shifts importance from volume to value, it is more important than ever to have a strategic approach to collecting and analyzing evidence. UBC offers a robust...
Biosimilars
UBC - September 06, 2016
Proving therapeutic equivalence is an important step in the approval process for a biosimilar. The research needed is time, labor and resource intensive, making it critical to maximize the investment. UBC’s Clinical Development team...
Pharma M&A
UBC - May 16, 2016
Patent expirations and mounting pricing pressures have fuelled record M&A activity throughout the pharma and biotech industry. This trend shows no sign of slowing down. In fact, PwC’s Health Research Institute predicts 2016 will...

Pages